Condition
Microtia, Congenital
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Withdrawn1
Completed1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07721805CompletedPrimary
Social Perception of Microtia
NCT07154667Not ApplicableRecruitingPrimary
Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
NCT03729427Not ApplicableWithdrawnPrimary
Rib Microtia and the Erector Spinae Plane (ESP) Block
NCT04192708Phase 4Unknown
Study of Analgesic Efficacy of Nerve Blocks on Otoplastic Surgery
Showing all 4 trials